Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

"We will also highlight the major events upcoming for us in the fourth quarter, namely anticipated completion of our Phase 2 trials of Brilacidin-OM for oral mucositis and Prurisol for psoriasis."

“These trials will provide perspectives as to how our drug candidates might progress toward tremendous market opportunities, as there is a need for a preventative medicine for oral mucositis and a new oral drug for psoriasis to challenge the current treatments.

How can Leo highlight the Prurisol 2b trial and talk about how that trial can "provide perspectives" if he has no trial results to frame the discussion?

Leo must release the interim Prurisol results before the conference if his discussion on P is to have any impact, significance, and credibility.